实时剪切波弹性成像对非酒精性脂肪性肝炎患者疗效的预测价值
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

四川省南充市市校合作科研专项(19SXHZ0237)


Clinical value of realtime shearwave elastography in predictinging the treatment effect of patients with nonalcoholic steatohepatitis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨实时剪切波弹性成像(SWE)对于非酒精性脂肪性肝炎(NASH)患者治疗效果的预测价值研究。方法 选取2020年1月~2021年1月在南充市中心医院确诊且有完整临床资料的NASH患者60例,应用SWE技术,采集治疗前后患者肝右叶及右肾实质的弹性模量平均值(E-Mean),收集患者生化、凝血等血清学指标,计算FIB-4指数,观察终点为6个月,根据治疗效果分为有效组和无效组。比较治疗前有效组和无效组间的肝E-Mean、肝肾EMean比值及FIB-4指数差异,分析治疗前后组内及组间的肝E-Mean、肝肾E-Mean比值及FIB-4指数的变化情况,并用ROC曲线评价肝E-Mean及肝肾E-Mean比值评估NASH患者预后的效能。结果 治疗前有效组的肝EMean、肝肾E-Mean比值及FIB4指数均低于无效组(P<0.05);治疗后有效组的肝E-Mean、肝肾E-Mean比值、FIB-4指数以及无效组的FIB-4指数均较治疗前降低(P<0.05),而无效组的肝E-Mean及肝肾E-Mean比值较治疗前反而有升高的趋势(P<0.05)。ROC结果显示,肝E-Mean评估NASH预后的AUC为0.763,灵敏度为67%,特异度为87%,截断值为9.93kPa。肝肾E-Mean比值评估NASH预后的AUC为0.828,灵敏度为78%,特异度为91%,截断值为1.89。结论 SWE技术可以动态监测NASH患者的治疗过程,提供的量化指标有预测NSAH患者治疗效果的潜能。

    Abstract:

    Objective To investigate the predictive value of real-time shearwave elastography (SWE) in the treatment effect of patients with non-alcoholic steatohepatitis (NASH).Methods A total of 60 NASH patients with complete clinical data were selected. Before and after treatment,SWE technology was used to collect the mean values of Elasticity modulus (E-Mean) of the right lobe of liver and right kidney parenchyma. At the same time,Serological indexes such as biochemical and blood coagulation were collected and FIB-4 index was calculated. The end point of observation was 6 months,and the patients were divided into effective group and ineffective group according to the treatment effect. The differences of liver E-mean, liver and kidney E-mean ratio and FIB-4 index between the effective group and the ineffective group before treatment were compared, and the changes of them within and between the groups before and after treatment were analyzed. The ROC curve was used to evaluate the efficacy of liver E-mean and liver-kidney E-mean ratio in evaluating the prognosis of NASH patients.Results Before treatment,the liver E-Mean,liver-kidney E-mean ratio and FIB-4 index of effective group were lower than those of ineffective group (P<0.05).After treatment, the liver E-mean, liver-kidney E-mean ratio,FIB-4 index in the effective group and the FIB-4 index in ineffective group were decreased compared with before treatment (P<0.05),while the liver E-mean and liver-kidney E-mean ratio in the ineffective group had a tendency to increase compared with before treatment (P<0.05). ROC results showed that the AUC, sensitivity, specificity and cutoff value of liver E-mean for NASH prognosis evaluation were 0.763,67%,87% and 9.93kPa, respectively. These parameters of liver-kidney E-mean ratio for NASH prognosis evaluation were 0.828, 78% , 91% and 1.89 respectively.Conclusions SWE can dynamically monitor the course of treatment in patients with NASH, and its quantitative indicators have the potential to predict treatment effect in patients with NSAH.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-08-19
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司